Comment from James Jocelyn
AnonymousSupportIndividual
Summary: An individual patient who successfully used peptide therapy to manage PCOS and insulin resistance supports the action to ensure patients maintain access to safe, regulated, and provider-guided therapies. She argues that restricting access through licensed providers may push patients toward unregulated sources.
I am a 41-year-old woman who spent years doing everything “right.” I exercised, tracked my nutrition, and tried every program I could find, yet I continued to struggle with my weight, inflammation, and energy. It wasn’t until I was diagnosed with PCOS and insulin resistance that I realized my body wasn’t failing me—I simply needed the right medical care.
Working with a licensed healthcare provider and incorporating peptide therapy into my treatment plan changed my life. I’ve lost over 45 pounds, my inflammation has improved, my energy is back, and for the first time in years, I feel healthy. These therapies didn’t replace a healthy lifestyle—they finally allowed my healthy lifestyle to work.
Since sharing my journey, I’ve heard from thousands of women who saw themselves in my story. So many have spent years searching for answers to PCOS, insulin resistance, perimenopause, and other health challenges before finally finding a provider who listened. Their stories remind me that I’m not the exception.
I respectfully ask the FDA to protect access to safe, regulated, provider-guided peptide therapies. If patients lose access through licensed medical providers, many won’t stop searching for answers—they’ll be pushed toward unregulated sources instead. Patients deserve the ability to work with their healthcare providers and make informed decisions about their own health.